Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christian,Boada

第一单位： From the Regenerative Medicine Program (C.B., A.Z., C.T., P.Z., J.O.M., K.H., T.N., MS., R.M., E.T.), Houston Methodist Research Institute (HMRI), TX.

作者： Christian,Boada ^[1] ; Assaf,Zinger ^[2] ; Christopher,Tsao ^[1] ; Picheng,Zhao ^[1] ; Jonathan O,Martinez ^[1] ; Kelly,Hartman ^[1] ; Tomoyuki,Naoi ^[1] ; Roman,Sukhoveshin ^[1] ; Manuela,Sushnitha ^[3] ; Roberto,Molinaro ^[1] ; Barry,Trachtenberg ^[4] ; John P,Cooke ^[1] ; Ennio,Tasciotti ^[5]

作者单位： From the Regenerative Medicine Program (C.B., A.Z., C.T., P.Z., J.O.M., K.H., T.N., MS., R.M., E.T.), Houston Methodist Research Institute (HMRI), TX. ^[1] Tecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Nuevo León, México (C.B.). ^[2] Department of Cardiovascular Sciences (R.S., J.P.C.), Houston Methodist Research Institute (HMRI), TX. ^[3] Department of Bioengineering, Rice University, Houston, TX (M.S.). ^[4] Department of Biomolecular Sciences, University of Urbino Carlo Bo, Italy (R.M.). ^[5] Houston Methodist DeBakey Heart and Vascular Center (J.P.C.), Houston Methodist Hospital, TX. ^[6] Department of Orthopedics and Sports Medicine (E.T.), Houston Methodist Hospital, TX. ^[7]

关键词 atherosclerosis biomimetic drug delivery system inflammation macrophages